CNSP insider buying

CNS Pharmaceuticals, Inc.

Every qualifying open-market purchase of CNSP reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in CNSP yet; if one forms, it appears here (and hits our alert subscribers in real time).

Clusters
0
Distinct insiders
1
Total bought
$10.0K
Market cap
Unknown

All notable open-market buys in CNSP

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
May 18, 2026
Director
2,000$5.00$10.0KSEC ↗

CNSP insider buying — FAQ

Are insiders buying CNSP stock?
1 insider has bought CNSP (CNS Pharmaceuticals, Inc.) on the open market, most recently on Aug 18, 2026. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
How much CNSP stock have insiders bought?
Insiders have bought a combined $10.0K of CNSP across 1 open-market purchase, based on SEC Form 4 filings.
What is an insider cluster buy in CNSP?
A cluster buy is two or more distinct CNS Pharmaceuticals, Inc. insiders — officers, directors, or 10% owners — each buying CNSP on the open market within a rolling window. None has been detected in CNSP yet.
Where does this CNSP insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in CNSP

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy CNSP within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding CNSP.